Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Funded Early Detection and Screening Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Metzger, Gregory John

University Of Minnesota
United States

Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 4R01CA241159-05 Guillermo Marquez, Ph.D.
Miyano, Masaru

Beckman Research Institute/City Of Hope
United States

Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D.
Mu, Ping

Yale University
United States

Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Nabavi, Sheida

University Of Connecticut Storrs
United States

SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D.
Nappi, Lucia

Provincial Health Services Authority
United States

Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. 5R37CA264798-03 Guillermo Marquez, Ph.D.
Nath, Kavindra

University Of Pennsylvania
United States

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition 5R01CA228457-05 Nicholas Hodges, Ph.D.
Neslund-Dudas, Christine Marie

Henry Ford Health + Michigan State University Health Sciences
United States

HFH-MSU CSRN ACCrual Enrollment and Screening Site 3UG1CA287007-02S1 Elyse LeeVan, M.D., M.P.H.
Oberg, Ann Laura

Mayo Clinic Rochester
United States

Management and Data Coordination Unit for PCDC 5U24CA274496-04 Guillermo Marquez, Ph.D.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 5R21CA274021-02 Guillermo Marquez, Ph.D.
Ostrin, Edwin Justin

University Of Tx Md Anderson Can Ctr
United States

Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort 1U01CA295902-01A1 Claire Zhu, Ph.D.
Pandharipande, Pari Vijay

Ohio State University
United States

Precision Management of Cystic Precursors to Pancreatic Cancer 5R01CA237133-06 Matthew Young, Ph.D.
Papadopoulos, Nickolas

Johns Hopkins University
United States

Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids 5U01CA230691-08 Nicholas Hodges, Ph.D.
Paulovich, Amanda G

Fred Hutchinson Cancer Center
United States

Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment 5U2CCA271873-03 Sidney Fu, M.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 Matthew Young, Ph.D.
Permuth, Jennifer B

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 5R37CA229810-07 Matthew Young, Ph.D.